PJSC PROMOMED is a leading innovative biopharmaceutical company with attractive growth potential in promising segments of the pharmaceutical market. The Company has unique R&D Hub and manufacturing plant named BIOKHIMIK. This allows PROMOMED to develop innovative medicines, be fast in responding to unmet needs in healthcare, implement up-to-date technology solutions. PROMOMED is ranked #1 in Obesity treatment segment and #1 in Russia in terms of the number of clinical trials and medical studies in 2022-2023. The Company has a diversified portfolio of more than 330 medicines and is represented in TOP-10 therapeutic areas in the local market: Onco, Diabetes, Obesity, Neuro, Rheuma, Pain, etc. More than 80% of PROMOMED products are listed as live-saving products in the local Essential Drug List.